Skip to main content
. 2017 Dec 27;15(3):2781–2788. doi: 10.3892/ol.2017.7690

Table II.

Expression of miR-193b in patients with patients with later-stage liver cancer.

Variables Crude OR (95% CI) P-value
Depth of invasion 0.002
  T1+T2 1
  T3+T4   4.01 (1.23–13.05)
Metastasis 0.08
  Negative 1
  Positive   3.77 (0.91–13.52)
Tumor differentiation 0.04
  Moderate-well 1
  Poor   3.82 (1.12–12.74)
Lauren type 0.04
  Adenocarcinoma 1
  Diffusion   4.02 (1.03–15.61)
UICC stage 0.001
  I+II 1
  III+IV 11.93 (2.21–39.89)

miR, microRNA; OR, odds ratio; UICC, Union for International Cancer Control.